
Sign up to save your podcasts
Or


The 'pink pill' flibanserin has been called 'the female Viagra', but critics argue its benefits are few and side effects many.
Melanie Abbott investigates how the failed anti-depressant came to be licensed in the USA, and what the future plans are to bring the drug to Europe.
Presenter: Melanie Abbott
By BBC Radio 44
77 ratings
The 'pink pill' flibanserin has been called 'the female Viagra', but critics argue its benefits are few and side effects many.
Melanie Abbott investigates how the failed anti-depressant came to be licensed in the USA, and what the future plans are to bring the drug to Europe.
Presenter: Melanie Abbott

7,878 Listeners

1,075 Listeners

5,580 Listeners

1,800 Listeners

589 Listeners

1,752 Listeners

1,037 Listeners

1,958 Listeners

9,085 Listeners

37,649 Listeners

100 Listeners

720 Listeners

12,637 Listeners

4,174 Listeners

3,218 Listeners

791 Listeners

15,516 Listeners

264 Listeners

105 Listeners

2,155 Listeners

907 Listeners

153 Listeners

299 Listeners

2,557 Listeners

1,206 Listeners